feed,title,long_url,short_url
InsiderMonkey,ProFrac Holding Corp. (ACDC): A Bull Case Theory,https://insidermonkey.com/blog/--1552822,
InsiderMonkey,"Goldman Picks ValvolineInc. (VVV) as a Buy, Targets $45",https://insidermonkey.com/blog/--1546753,
InsiderMonkey,10 Trending AI Stocks on Wall Street Right Now,https://insidermonkey.com/blog/--1557364,
InsiderMonkey,Top Energy and Utility Stocks Wall Street Analysts Are Talking About,https://insidermonkey.com/blog/--1556454,
InsiderMonkey,VSE Corporation (VSEC): A Bull Case Theory,https://insidermonkey.com/blog/--1551287,
InsiderMonkey,CRISPR Therapeutics AG (CRSP): A Bull Case Theory,https://insidermonkey.com/blog/--1551289,
InsiderMonkey,"Core Natural Resources, Inc. (CNR): A Bull Case Theory",https://insidermonkey.com/blog/--1551292,
InsiderMonkey,11 Best Performing Warren Buffett Stocks in 2025,https://insidermonkey.com/blog/--1557048,
InsiderMonkey,"PayPal Holdings, Inc. (PYPL): A Bull Case Theory",https://insidermonkey.com/blog/--1551297,
InsiderMonkey,10 Best AI Stocks to Buy According to Billionaire David Tepper,https://insidermonkey.com/blog/--1555508,
InsiderMonkey,Piper Sandler Reiterates a Buy Rating on Opko Health (OPK) With a $3 PT,https://insidermonkey.com/blog/--1556642,
InsiderMonkey,"Leerink Partners Slashes MannKind Corporation’s (MNKD) Price Target to $7, Keeps a Buy Rating",https://insidermonkey.com/blog/--1556643,
InsiderMonkey,Craig-Hallum Maintains a Buy Rating on Bit Digital (BTBT),https://insidermonkey.com/blog/--1556645,
InsiderMonkey,Leerink Partners Maintains a Buy Rating on Ardelyx (ARDX) With a $10 PT,https://insidermonkey.com/blog/--1556646,
InsiderMonkey,ImmunityBio (IBRX) Attains FDA’s Expanded Access Authorization for its Cancer BioShield Platform Anchored by ANKTIVA,https://insidermonkey.com/blog/--1556647,
InsiderMonkey,Jefferies Maintains a Buy on Taysha Gene Therapies (TSHA) With an $8 PT,https://insidermonkey.com/blog/--1556648,
InsiderMonkey,BofA Remains Bullish on Sana Biotechnology (SANA),https://insidermonkey.com/blog/--1556649,
InsiderMonkey,Canaccord Genuity Maintains a Buy on Inventiva (IVA) With a $20 Price Target,https://insidermonkey.com/blog/--1556651,
InsiderMonkey,"BofA Reiterates a Buy Rating on Relay Therapeutics (RLAY), Sets a $17 PT",https://insidermonkey.com/blog/--1556652,
InsiderMonkey,Maxim Group Maintains a Buy on Atai Life Sciences (ATAI) With a $6 Price Target,https://insidermonkey.com/blog/--1556653,
